Epstein Secrets

That determination raises questions about an FBI document that seems to identify Epstein as providing information to the bureau." NBC News (11/13, Fitzpatrick, 6.14M) reports, "The Justice Department's Office of Professional Responsibility found that former Labor Secretary Alex Acosta, who oversaw the cas

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

That determination raises questions about an FBI document that seems to identify Epstein as providing information to the bureau." NBC News (11/13, Fitzpatrick, 6.14M) reports, "The Justice Department's Office of Professional Responsibility found that former Labor Secretary Alex Acosta, who oversaw the cas

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

That determination raises questions about an FBI document that seems to identify Epstein as providing information to the bureau." NBC News (11/13, Fitzpatrick, 6.14M) reports, "The Justice Department's Office of Professional Responsibility found that former Labor Secretary Alex Acosta, who oversaw the cas

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying